SIREN : 789626405
ERIC'S DRAGUI BIO is a French company founded 13 years ago, specialized in the sector Supermarchés. Based in TRANS-EN-PROVENCE (83720), this company of category PME shows in 2024 a revenue of 8.4 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-04-18
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2024 | 2017 | 2016 |
|---|---|---|---|
| Revenue | 8 403 495 € | N/C | 11 308 774 € |
| Net income | 353 191 € | 213 158 € | 312 744 € |
| EBITDA | 556 045 € | N/C | 562 876 € |
| Net margin | 4.2% | N/C | 2.8% |
In 2024, ERIC'S DRAGUI BIO achieves revenue of 8.4 M€. Activity remains stable over the period (CAGR: -3.6%). After deducting consumption (6.2 M€), gross margin stands at 2.2 M€, i.e. a rate of 26%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 556 k€, representing 6.6% of revenue. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 353 k€, i.e. 4.2% of revenue. This profit can be retained or distributed to shareholders.
8 403 495 €
2 207 732 €
556 045 €
434 281 €
353 191 €
6.6%
The debt ratio (= Financial debt / Equity x 100) stands at 21%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 46%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 0.4 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 5.6% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. Satisfactory level allowing partial financing of growth.
21.0%
46.059%
5.641%
0.399
31.4%
In 2024, the debt ratio of ERIC'S DRAGUI BIO (21.00) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2024, the financial autonomy of ERIC'S DRAGUI BIO (46.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2024, the repayment capacity of ERIC'S DRAGUI BIO (0.40) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
The liquidity ratio (= Current assets / Current liabilities) stands at 151.72. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 1.6x. Coverage is limited: any activity downturn would jeopardize interest payments.
151.715
1.557
In 2024, the liquidity ratio of ERIC'S DRAGUI BIO (151.72) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2024, the interest coverage of ERIC'S DRAGUI BIO (1.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 1 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 34 days. Excellent situation: suppliers finance 33 days of the operating cycle (retail model). Inventory turnover is 27 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 38 days of revenue, i.e. 879 k€ to permanently finance. Over 2016-2024, WCR increased by +31%, requiring additional financing.
878 838 €
1 j
34 j
27 j
38 j
Based on 551 transactions of similar company sales in 2024, the value of ERIC'S DRAGUI BIO is estimated at 2 305 619 € (range 958 899€ - 4 793 675€). With an EBITDA of 556 045€, the sector multiple of 4.7x is applied. The price/revenue ratio is 0.23x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 551 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare ERIC'S DRAGUI BIO with other companies in the same sector:
The revenue of ERIC'S DRAGUI BIO in 2024 is 8.4 M€.
Yes, ERIC'S DRAGUI BIO generated a net profit of 353 k€ in 2024.
The headquarters of ERIC'S DRAGUI BIO is located in TRANS-EN-PROVENCE (83720), in the department Var.
The tax return of ERIC'S DRAGUI BIO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
ERIC'S DRAGUI BIO operates in the sector Supermarchés (NAF code 47.11D). See the 'Sector positioning' section above to compare the company with its competitors.